BriaCell Therapeutics Corp. (NASDAQ:BCTX – Get Free Report) saw a significant growth in short interest in October. As of October 15th, there was short interest totalling 727,600 shares, a growth of 62.0% from the September 30th total of 449,200 shares. Currently, 2.3% of the shares of the stock are sold short. Based on an average daily volume of 4,780,000 shares, the days-to-cover ratio is currently 0.2 days.
Institutional Inflows and Outflows
An institutional investor recently bought a new position in BriaCell Therapeutics stock. Vontobel Holding Ltd. bought a new position in BriaCell Therapeutics Corp. (NASDAQ:BCTX – Free Report) during the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund bought 80,000 shares of the company’s stock, valued at approximately $99,000. Vontobel Holding Ltd. owned approximately 0.44% of BriaCell Therapeutics at the end of the most recent reporting period. Institutional investors and hedge funds own 15.42% of the company’s stock.
BriaCell Therapeutics Price Performance
Shares of BCTX traded up $0.01 on Monday, hitting $0.88. The company’s stock had a trading volume of 498,809 shares, compared to its average volume of 1,645,892. The company has a market capitalization of $16.06 million, a PE ratio of -0.69 and a beta of 1.34. BriaCell Therapeutics has a fifty-two week low of $0.46 and a fifty-two week high of $5.97. The company has a 50 day moving average price of $0.79 and a 200 day moving average price of $1.17.
Analyst Upgrades and Downgrades
BriaCell Therapeutics Company Profile
BriaCell Therapeutics Corp., a clinical stage immuno-oncology company, engages in developing targeted immunotherapies to transform cancer care. Its lead candidate is Bria-IMT, a targeted cell-based immunotherapy that is being evaluated in a pivotal Phase 3 combination study for metastatic breast cancer.
Featured Articles
- Five stocks we like better than BriaCell Therapeutics
- Best Stocks Under $10.00
- Inflation Risk Rising, Key Trades Investors Are Making Now
- How to Calculate Return on Investment (ROI)
- 3 Oil Stocks to Watch Before Earnings Come Out
- CD Calculator: Certificate of Deposit Calculator
- Is American Express Stock’s Sell-the-News Reaction a Buying Opp?
Receive News & Ratings for BriaCell Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BriaCell Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.